RSS   Newsletter   Contact   Advertise with us

Cardiome Pharma appoints Justin Renz as CFO

Staff Writer | Vancouver, BC, Canada | May 17, 2017
Cardiome PharmaCardiome Pharma, a pharmaceutical company, announced that Justin Renz joins Cardiome as its new chief financial officer.
Mr. Renz has extensive experience in the biopharmaceutical industry.

He most recently served as Executive Vice President, Chief Financial Officer and Treasurer at Karyopharm Therapeutics, which he joined in August 2014, where he led core business and finance functions.

Prior to Karyopharm, Mr. Renz was Executive Vice President, Chief Financial Officer and Treasurer at Zalicus Inc. (formerly CombinatoRx, Inc.), which he joined in September 2006.

Mr. Renz oversaw multiple rounds of equity and debt financing and led the company's asset monetization strategy and two reverse mergers.

Prior to Zalicus, he served in senior finance and accounting roles at Serono, Inc. and Coley Pharmaceutical Group, Inc.

Earlier in his career, he held increasingly senior finance positions at ArQule, Inc. and Millipore Corporation.

Mr. Renz began his career with Arthur Andersen LLP in 1993.

Mr. Renz received a Bachelor of Arts in Economics and Accounting from the College of the Holy Cross, a Master of Science in Taxation from Northeastern University and a Master of Business Administration from Suffolk University.


 LATEST MOVES FROM British Columbia 


MORE INSIDE POST